Ibritumomab Tiuxetan and Methyl aminolevulinate Topical application
Determining the interaction of Ibritumomab Tiuxetan and Methyl aminolevulinate Topical application and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ibritumomab
Brand name: Y-90 Zevalin, In-111 Zevalin
Synonyms: Ibritumomab
Generic Name: methyl aminolevulinate topical
Brand name: Metvixia
Synonyms: Methyl aminolevulinate (topical), Methyl Aminolevulinate
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ibritumomab Tiuxetan-Methyl B-12 vitamin B12
- Ibritumomab Tiuxetan-Methyl Salicylate and Menthol Cream and Ointment
- Ibritumomab Tiuxetan-Methyl Salicylate and Menthol Lotion
- Ibritumomab Tiuxetan-Methyl salicylate topical
- Ibritumomab Tiuxetan-Methyl Salicylate, Menthol, and Camphor
- Ibritumomab Tiuxetan-Methyl Salicylate, Menthol, and Capsaicin Cream and Ointment
- Methyl aminolevulinate Topical application-Ibrutinib
- Methyl aminolevulinate Topical application-Ibrutinib Capsules
- Methyl aminolevulinate Topical application-Ibrutinib Tablets
- Methyl aminolevulinate Topical application-Ibu
- Methyl aminolevulinate Topical application-IBU Tablets
- Methyl aminolevulinate Topical application-Ibu-2